Last reviewed · How we verify
NCT05918289: BAAEP
Improving Wellbeing in Older Adults: The Impact of an Active Aging Education Program in Pakistan
NA trial testing Blended& integrated happy aging active aging program(BIHAAAP) in Aging Well in 140 participants. Completed in 1 December 2022.
15 November 2022
Quick facts
| Lead sponsor | Zhengzhou University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 15 August 2022 |
| Primary completion | 15 November 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Blended& integrated happy aging active aging program(BIHAAAP)
Conditions studied
- Aging Well — all drugs for Aging Well →
- Well Aging — all drugs for Well Aging →
- Quality of Life — all drugs for Quality of Life →
- Well-Being, Psychological — all drugs for Well-Being, Psychological →
Sponsor
Zhengzhou University
Who can join
Adults 60 to 85, any sex, with Aging Well or Well Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized control trial study is to evaluate the effect of the happy aging education program on active aging determinants, and quality of life among community-based Muslim older adults compared with the control group who avail only health education. Q1.• What is the effect of the BIHAAAP on physical, mental, and behavioral aspects of active aging among community-dwelling older adults in the compression to the control group who only avail health education? Q2. What is the effect of the BAAEP on the quality of life among community-dwelling older adults in Pakistan? Treatment: (1) Face-to-face: 6 days, (2) home-based 12 weeks. 1. Face to Face: (1) Orientation, the aging process, the importance of exercises in old age, coping strategies, and the beneficial effects of body movements in Muslim prayers. (2) Hands-on training regarding proper body movement in Muslim five-time prayers. 2. Home-based treatment: (1) A Pictorial booklet consisting of tips to spend happy life in old age and a workbook to complete. (2) Audio video recorded by a physiotherapist on the proper body movements in five-time prayers to follow at home shared through whats app number of at least one family member if the person does not have a smartphone. Comparison group: One-day orientation. After the trial, the control group availed of the booklet and video-recorded Muslim prayers-like exercises.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05918289
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging Well
Currently open trials in the same condition.
- NCT06507189 — Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX) · NA · recruiting
- NCT05910619 — Transcranial Pulse Stimulation of the Brain · NA · recruiting
- NCT06204562 — Feasibility and Effects of Laughter-imitation Therapy (LIT) · NA · active not recruiting
- NCT05920733 — Healthy Lifetime - Phase 2 · NA · recruiting
- NCT06217601 — Impact Evaluation of the Digital Connect Project for Homebound Older Adults · NA · active not recruiting
Other Zhengzhou University trials
Trials by the same sponsor.
- NCT07299331 — Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma · NA · not yet recruiting
- NCT07264894 — ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Tria · Phase 4 · not yet recruiting
- NCT07198464 — Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Sintilima · NA · not yet recruiting
- NCT07117305 — CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation · Phase 1, PHASE2 · not yet recruiting
- NCT06609304 — Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05918289 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhengzhou University
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05918289.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing